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(4) The Fellow must provide evidence of a guaranteed position
in a medical institution upon return to the home country.
(5) Fellows will receive a stipend from the Society such that,
taking into account the home country and/or the host
institution support that they may have, they achieve a
$22,500 US revenue.
(6) Fellows must be able to read and speak the language of
the host country. An interview may be required to assess
verbal fluency.
(7) Fellowships will be offered primarily for clinical training of
one to two years duration.
(8) Clinical training programs should be practical in their
orientation, and applicable to the needs and conditions of
the home country. The ability of the host institution to
provide such training will be an important factor in the
selection process.
(9) Fellows must have received sufficient training in internal
medicine or other fields to pass all host country examina-
tions that are necessary to the care of patients. Fellow-
ships may be awarded to senior individuals who seek
additional training but, in general, preference will be given
to younger physicians who are at the beginning of their
permanent careers.
(10) Specific instructions and the necessary application forms
can be obtained by writing directly to Jan J. Weening,
M.D., Academic Medical Center, Meibergdreef 9, 1105
AZ Amsterdam, The Netherlands.
FOR SUBMISSION OF MANUSCRIPTS AND
ANNOUNCEMENTS
New manuscripts and related editorial correspondence for
Kidney International should be sent to:
Saulo Klahr, M.D.
Editor, Kidney International
Barnes-Jewish Hospital, North Campus
Department of Medicine
216 South Kingshighway
St Louis, Missouri 63110 USA
Telephrie numbers for the Editorial Office are:
(314) 454-8919
(314) 454-8916
(314) 454-7107
The FAX number is (314) 454-8907.
E-mail correspondence may be sent to: snewell @imgate.wus-
tl.edu
Errata
Kidney International Volume 52 Supplement 60, Experimental
Approaches to Diabetic Nephropathy, September 1997. On the
heading to the Table of Contents in this supplement, the volume
number was mistakenly printed as Volume 51. Readers will please
note for future reference that the correct volume number is
Volume 52. The Editors and Publisher regret the error.
KEE N, MCTAVISFI AJ, PAPILLON J, CYBULSKY AV. Receptor
protein tyrosine kinases in perinatal developing rat kidney. Kidney
mt 52:309—317.
Due to a production error, Figures 2 and 3 of the article cited
above were not printed clearly. The figures and their legends are
reprinted below. The publisher regrets the error.
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Fig. 2. Expression and tyrosine
phosphorylation of EGF-R (Mr 170k), PDGF-
IP: anti-FGF-R3 I : a ti- lk- Ra (180k), FGF-R3 (120k), and Flk-l (205k).
Blot: ti- F-R3 l t: ti I For each PTK, the upper panel demonstratesprotein expression and the lower panel shows
endogenous tyrosine phosphorylation and in
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Vitro autophosphorylation. In each lower panel,
membranes were preincubated with ATP (+, in
vitro tyrosine autophosphorylation assay) or205 k —' were untreated (endogenous tyrosine120 k -' phosphorylation). EGF-R and PDGF-Ro: The
lower hand in the upper panels probably
ATP + + ATP + + represents a degradation product. Abbreviations
are: FK, fetal kidney; AK, adult kidney; AH,
IP: anti-FGF-R3 lP: anti-Flk-1 adult heart; ALi, adult liver; ALu, adult lung;
Blot: anti-P-tyr Blot: anti-P-tyr IP, immunoprecipitation; P-tyr,phosphotyrosine.
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Fig. 3. Protein expression of FGF-R1 (155k,1 50 k 150k, and 125k), Met (145k), Tie-2 (150k),
F-R FGF-R4 (95k), and PDGF-Rfl (180k). FGF-R1:Three specific bands are present; the uppermost
: nti- i - band is nonspecific. Met: The upper band
 anti- probably represents the unprocessed Metprecursor. Tie-2: The upper and lower panels
represent two different patterns of Tie-2 protein
1 80 - expression in adult kidneys. PDGF-Rj'3: The
bands above and below the 180k band, present
in the four lanes, are nonspecific. Abbreviation
IP Ab + + is: IP Ab+, immunoprecipitation with specific
antibody; the control immunoprecipitations inIP. anti-PDG - the first two lanes were performed using
Blot: antu-PDGF-R13 nonimmune IgG.
